| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| R&D Expense | $27.2M | +77.2% |
| SG&A Expense | $6.2M | -22.5% |
| Operating Income | -$33.3M | -43.2% |
| Pre-tax Income | $4.9M | +124.3% |
| Net Income | -$4.8M | +76.4% |
| EPS (Basic) | -$0.29 | +77.7% |
| EPS (Diluted) | -$0.29 | +77.7% |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $862K | -95.9% |
| Current Assets | $3.7M | -86.4% |
| Total Assets | $5.9M | -78.4% |
| Current Liabilities | $7.5M | +314.2% |
| Stockholders' Equity | -$2.7M | +28.9% |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.1M | -1.6% |
| Capital Expenditures | $457K | — |
| Investing Cash Flow | -$682K | — |
| Financing Cash Flow | $4.4M | +11.7% |
| Free Cash Flow | -$24.6M | — |